Effects of an herbal supplement on quality of life in patients with gastrointestinal cancers

Effects of an herbal supplement containing Allium sativum, Panax ginseng, Curcuma longa and green tea on quality of life in patients with common upper gastrointestinal cancers

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017030416776N2

Enrollment

Registered

2017-09-20

Start date

2017-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancers of oesophagus and stomach. Oesophagus, unspecified

Interventions

Intervention 1: Patients in control group are given placebo solution (sacarose 65%) 20 cc three times a day for 60 consecutive days. All subjects will receive conventional treatments for cancer. Inter

Placebo

Treatment - Drugs

Patients in control group are given placebo solution (sacarose 65%) 20 cc three times a day for 60 consecutive days. All subjects will receive conventional treatments for cancer.

Patients in intervention group are given polyherbal solution (containing extracts of garlic, green tea and Curcuma longa and powder of Panax ginseng) 20 cc three times a day for 60 consecutive days. A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with cancers of esophagus or stomach; Normal liver enzymes; Hb more than 9 g/dL; Platelet more than 100000; Creatinine less than 1.5 mg/dl. Exclusion criteria: Patients with severe complication of cancer; Induction of toxicity by the herbal supplement; Pregnancy; Consumption of anticoagulant drugs

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Quality of life. Timepoint: 30 days and 60 days after beginning of study. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ahmad Ghorbani

Mashhad University of Medical Sciences

ghorbania@mums.ac.ir+98 51 3800 2256

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026